search
Back to results

Prediction and Maintenance of Sinus Rhythm Among Atrial Fibrillation Patients

Primary Purpose

Atrial Fibrillation

Status
Terminated
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Unique measurement (AutoSTRAIN) by a commercial software program (TOMTEC-ARENA)
Sponsored by
Crystal Blake-Parlin
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Atrial Fibrillation

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • • Patients identified at PBMC with a documented diagnosis of AF (at any point in time) and who have undergone any cardioversion.

    • The patient would also need to have had an echocardiogram within six months pre-cardioversion (performed for any reason) with a well visualized atrial roof in order to perform the measurements accurately using the TOMTEC-ARENA software.

Exclusion Criteria:

  • • Patients with a mitral regurgitation greater than moderate (effective regurgitant orifice >= .2 mm2)

    • Patients with post-surgical valve repair or replacement, if the procedure was done with a thoracotomy
    • Any patient how has had any cardiac surgery requiring a thoracotomy

Sites / Locations

  • Pen Bay Medical Center

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Patients identified at PBMC with a documented diagnosis of AF

Arm Description

Patients identified at PBMC with a documented diagnosis of AF (at any point in time) and who have undergone any cardioversion.

Outcomes

Primary Outcome Measures

Number of Patients With a Relationship Between Left Atrial Global Longitudinal Strain and the Maintenance of Sinus Rhythm After Cardioversion
Left atrial global longitudinal strain as measured utilizing the TOMTECH - ARENA software program compared to duration of the maintenance of sinus rhythm following elective cardioversion. Time, in months, sinus rhythm was maintained.

Secondary Outcome Measures

Full Information

First Posted
January 29, 2019
Last Updated
July 20, 2023
Sponsor
Crystal Blake-Parlin
Collaborators
MaineHealth
search

1. Study Identification

Unique Protocol Identification Number
NCT04313296
Brief Title
Prediction and Maintenance of Sinus Rhythm Among Atrial Fibrillation Patients
Official Title
Prediction and Maintenance of Sinus Rhythm Among Atrial Fibrillation Patients
Study Type
Interventional

2. Study Status

Record Verification Date
July 2023
Overall Recruitment Status
Terminated
Why Stopped
Staff shortage
Study Start Date
May 1, 2020 (Actual)
Primary Completion Date
September 6, 2022 (Actual)
Study Completion Date
September 6, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Crystal Blake-Parlin
Collaborators
MaineHealth

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
No

5. Study Description

Brief Summary
Atrial fibrillation (AF) is the most common heart rhythm disorder seen in clinical practice, with an estimated 2.7-6.1 million people in the U.S. affected by the disorder [1]. Previous studies have demonstrated that left atrial volume is a predictive measure of incident atrial fibrillation [2]. This study aims to add to the literature by investigating predictive measures of left atrial global longitudinal strain (LA GLS) that would be suggestive of maintenance of normal sinus rhythm post cardioversion. If the investigators could gain insight on the connection between LA GLS and cardioversion among patients with atrial fibrillation, the investigators could potentially help the clinical management of patients pre/post cardioversion, and potentially change poor outcomes.
Detailed Description
Atrial fibrillation (AF) is a heart rhythm disorder in which the normal beating in the upper chambers of the heart is irregular, leading to poor blood flow to the lower chambers. Risk factors include older age, high blood pressure, obesity, European ancestry, diabetes, heart failure, ischemic heart disease, hyperthyroidism, chronic kidney disease, heavy alcohol use, and enlarged heart chambers on the left side [3]. AF increases a person's risk for stroke and contributes to an estimated 130,000 deaths each year [1]. Treatment generally includes medication, surgery, and/or healthy lifestyle changes [1]. Electrical cardioversion, in which the patient must undergo sedation or general anesthesia, is also used to convert patients with persistent AF to normal sinus rhythm. Electrical cardioversion has been associated with a high initial success rate of 68-98% [4], but long-term maintenance of sinus rhythm has proved challenging [5]. Due to the potential risks incurred to the patient, it is important to understand which patients are good candidates for cardioversion therapy. A review article describes that duration of AF, sex, age, weight smoking status, number of shocks at cardioversion, post-ablation procedure, medications, hypertension, diabetes, Chronic Obstructive Pulmonary Disease (COPD), obstructive sleep apnea, renal impairment, hyperthyroidism, coronary artery disease, congestive heart failure, left systolic dysfunction, left diastolic dysfunction, left ventricular hypertrophy, valvular heart disease, and left atrial size have each been found to be associated with maintenance of sinus rhythm [6]. Echocardiography has been increasing used in understanding the cardiac structure and risk of stroke among patients with AF, with left atrial size, left ventricular wall thickness, and left ventricular dysfunction recognized as independent predictors of AF [7]. Increasing evidence supports that the left atrial strain measurements can be a predictor of outcomes among AF patients, including stroke and AF recurrence after catheter ablation [8], [9]. The investigators aim to further explore left atrial strain measurements, including left atrial global longitudinal strain (LA GLS), as predictors of maintenance of normal sinus rhythm post- cardioversion. It is anticipated that a lower LA GLS will predict AF recurrence. To do this, the investigators will study patients with AF at Pen Bay Medical Center who have undergone cardioversion, measuring their LA GLS pre-cardioversion, and assess maintenance of sinus rhythm 6 months post-cardioversion. It is anticipated that this study will confirm LA GLS as a marker for maintenance of sinus rhythm post-cardioversion.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Atrial Fibrillation

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
This is a retrospective and prospective cohort study of patients with atrial fibrillation (AF) identified at Pen Bay Medical Center (PBMC). Patients will be identified for inclusion in the study based on a previous documented diagnosis of AF, have a documented echocardiogram, and have undergone electrical cardioversion, with a study enrollment goal of 150 patients.
Masking
None (Open Label)
Allocation
N/A
Enrollment
209 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Patients identified at PBMC with a documented diagnosis of AF
Arm Type
Experimental
Arm Description
Patients identified at PBMC with a documented diagnosis of AF (at any point in time) and who have undergone any cardioversion.
Intervention Type
Device
Intervention Name(s)
Unique measurement (AutoSTRAIN) by a commercial software program (TOMTEC-ARENA)
Intervention Description
The historic echocardiograms from patients who meet the study inclusion criteria will be uploaded into this software, which was newly acquired by the PBMC Cardiology Department. MaineHealth Information Services are currently working with study staff to assure appropriate security compliance within the network. LA GLS has not been routinely collected previously from echocardiograms performed at PBMC because of a lack of such technology.
Primary Outcome Measure Information:
Title
Number of Patients With a Relationship Between Left Atrial Global Longitudinal Strain and the Maintenance of Sinus Rhythm After Cardioversion
Description
Left atrial global longitudinal strain as measured utilizing the TOMTECH - ARENA software program compared to duration of the maintenance of sinus rhythm following elective cardioversion. Time, in months, sinus rhythm was maintained.
Time Frame
12 months

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: • Patients identified at PBMC with a documented diagnosis of AF (at any point in time) and who have undergone any cardioversion. The patient would also need to have had an echocardiogram within six months pre-cardioversion (performed for any reason) with a well visualized atrial roof in order to perform the measurements accurately using the TOMTEC-ARENA software. Exclusion Criteria: • Patients with a mitral regurgitation greater than moderate (effective regurgitant orifice >= .2 mm2) Patients with post-surgical valve repair or replacement, if the procedure was done with a thoracotomy Any patient how has had any cardiac surgery requiring a thoracotomy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Crystal Blake-Parlin
Organizational Affiliation
Pen Bay Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Pen Bay Medical Center
City
Rockport
State/Province
Maine
ZIP/Postal Code
04856
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Prediction and Maintenance of Sinus Rhythm Among Atrial Fibrillation Patients

We'll reach out to this number within 24 hrs